With one of Europe’s best research and business environment, excellent links with Europe and the World, a vibrant world-class lifestyle as well as superb conditions for an efficient relocation, the candidacy of Milan fully supports the objective of ensuring continuity in the activity of the European Medicines Agency (EMA) during the post-Brexit transition from London.
Italy has the second largest pharmaceutical industry in Europe in terms of production volumes and is the world’s largest exporter of medicines per capita, with 60% of the country’s production taking place in the Lombardy Region.
Significant investment is made in the pharmaceutical sector in Lombardy:
Milano offers Europe at your fingertips, Ema Milano
Milan is served by three major airports: Malpensa (MXP), with a wide network of European and international destinations; Linate (LIN), with convenient connections to European and Italian cities; and Orio al Serio (BGY), an operating base for all major European low-cost airlines. Nearly 1,300 weekly flights link Milan to 27 EU capitals.
Milano offers the Pirelli Building as site for the EMA.
The Pirelli Building (named “The Pirellone”) is one of Milan’s landmark building, designed by acclaimed architect Gio Ponti in the 1950s and recently fully renovated, it’s few meters away from the railaway Central Station. The building is an imposing architectural work that stands 127 metres tall, an expression of lightness and rationality in glass, aluminium and steel.
See below the promotional video of EMA MILANO.